Published by: Elsevier
https://www.journals.elsevier.com/molecular-therapy-oncolytics
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 793 | 99 | 118 | 27 |
The objective of the journal is to combine knowledge in the areas of Cancer research, Oncolytic virus, Cancer, Virus and Immune system. Tumor microenvironment is part of Cancer research studies tackled in it. The Oncolytic virus works featured in it incorporate elements from Interferon and Viral replication.
Carcinogenesis and Breast cancer are all topics related to Cancer research discussed. In addition to Virus research, Molecular Therapy - Oncolytics aims to explore topics under Vaccinia and Innate immune system. Molecular Therapy - Oncolytics tackles topics on Immune system, which can potentially contribute to the wider field of Immunology.
The tackled Immunotherapy research is interrelated with Antigen which concerns subjects like Antibody and Cytotoxic T cell. Molecular Therapy - Oncolytics facilitates discussions on Metastasis that incorporate concepts from other fields like microRNA and Gene knockdown. While Molecular Therapy - Oncolytics focused on Chimeric antigen receptor, it was also able to explore topics like Cell therapy and CD19.
The journal publications focus largely on the fields of Cancer research, Oncolytic virus, Immune system, Immunotherapy and Chimeric antigen receptor. Cancer research research presented in the journal papers is mostly focused on the subject of Tumor microenvironment. The most cited papers with studies in Oncolytic virus featured incorporate elements of Cancer cell and Interferon.
Molecular Therapy - Oncolytics was organized to reinforce research efforts on Cancer research, Cancer, Oncolytic virus, Immune system and Immunotherapy. Tumor microenvironment is a major topic of Cancer research research. Molecular Therapy - Oncolytics focuses on Cancer but the discussions also offer insight into other areas such as Autophagy and Disease.
It deals with Oncolytic virus in conjunction with Interferon and similar fields in Innate immune system. Topics in Immune system explored in the journal were investigated in conjunction with research in Bladder cancer and Colorectal cancer. While work presented in the journal provided substantial information on Immunotherapy, it also covered topics in Oncology and Glioma.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Molecular Therapy - Oncolytics (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Molecular Therapy - Oncolytics (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.92% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 22.97% were posted by at least one author from the top 10 institutions publishing in the journal. Another 15.54% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 25.00% of all publications and 36.49% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
One important aspect of Oncolytics and its applications in the field that the article omits is how professionals like Nurse Practitioners can use these research findings in real-world scenarios. Once researchers uncover new treatments and therapies, skilled Nurse Practitioners are often on the front lines, executing these treatments and monitoring their effects.
Arming these professionals with research knowledge is paramount. Hence, education becomes essential. In New York, for aspiring Nurse Practitioners, there are specific nurse practitioner program requirements new york you must meet before you can start practicing. These requirements typically align with the state’s healthcare needs and preferences.
Becoming a Nurse Practitioner with a specialty in Oncolytics can be rewarding professionally, and it provides an opportunity to significantly contribute to patients' lives. However, the journey requires dedication to meeting rigorous educational and experiential requirements.
Professionals seeking to explore this line must understand that research topics such as Cancer, Innate Immune System, or Molecular Therapy - Oncolytics, are just the tip of the iceberg. In reality, they will be managing complex cases that often require a combination of various modalities of treatment based on the latest research findings.
In the context of Molecular Therapy - Oncolytics, it's vital for these professionals to stay educated and keep pace with the latest research. This not only helps their professional development but also allows them to offer the best possible care to their patients.
Hamed Mirzaei;Michael R. Hamblin
(2020)Anna Schwendenwein;Zsolt Megyesfalvi;Zsolt Megyesfalvi;Nandor Barany;Nandor Barany;Zsuzsanna Valko
(2021)Xiangyu Zhao;Junfang Yang;Xian Zhang;Xin-An Lu
(2020)Simon Loff;Josephine Dietrich;Jan-Erik Meyer;Julia Riewaldt
(2020)Runzhe Shu;Vera J. Evtimov;Maree V. Hammett;Nhu-Y N. Nguyen
(2021)Rui Ma;Sin Wa Wong;Lilin Ge;Lilin Ge;Chris Shaw
(2020)Anahid Jewett;Janko Kos;Kawaljit Kaur;Tahmineh Safaei
(2020)Minkyu Jung;Minkyu Jung;Yanping Yang;Jaclyn E. McCloskey;Marjan Zaman
(2020)Amin Aalipour;Fabrice Le Boeuf;Fabrice Le Boeuf;Matthew Tang;Matthew Tang;Surya Murty
(2020)Constanze Slabik;Maja Kalbarczyk;Simon Danisch;Reinhard Zeidler
(2020)For those interested in medical careers beyond traditional medicine, numerous online programs offer flexible and accelerated pathways. Nurses looking to advance their education might explore rn to bsn with no clinical hours programs, which provide a convenient way to earn a Bachelor of Science in Nursing without the need for extra clinical practice.
For advanced practice nurses aiming to elevate their qualifications, the shortest online dnp program options offer a streamlined route to a Doctor of Nursing Practice degree. These programs combine rigorous academics with the convenience of online study, shortening the pathway to higher credentials.
Those new to healthcare might consider the fastest medical assistant program, which can prepare students for entry-level roles in a matter of weeks. These accelerated courses provide essential skills quickly, enabling fast entry into the healthcare workforce.
Additionally, for nurses seeking less demanding programs, researching dnp programs can reveal options that balance quality education with manageable coursework and requirements.
